AzTrials
AzTrials

Metabolic SyndromeNCT00525629

The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome

A study testing Walnuts in people with Metabolic Syndrome and Type 2 Diabetes, run by Christos Mantzoros at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Walnuts include many potentially beneficial micronutrients and phytochemicals, in this study we propose to examine the effects of walnuts independent of macronutrient content. The purpose of this proposal is to study in depth the short-term effects of walnut consumption in men and women with the metabolic syndrome. Read more about this study

Who is it for?
Ages 40 to 75 yearsHealthy volunteers can take part
What is being tested?
Walnuts
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
Feb 2007to Dec 2008
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Metabolic Syndrome is defined as follows:
  • Central Obesity- for Europid men this is a waist circumference of > 94cm for women >80cm or BMI >30.
  • Plus 2 of the following 4 factors
  • Elevated triglycerides: > 150 mg/dL
  • Reduced HDL cholesterol < 40 mg/dL in men and < 50 mg/dL in women.
  • Raised diastolic blood pressure systolic BP > 130mmHg or diastolic BP > 85mmHg or treatment with antihypertensives.
  • Raised fasting plasma glucose > 100mg/dL or previously diagnosed type II diabetes.

Who cannot join

  • Subjects with diabetes requiring medication or insulin are excluded.
  • Subjects with any medical condition or on any treatment, which would interfere with the study outcomes or would make participation potentially harmful such as pregnancy or breastfeeding, anemia, heart disease, stroke, malabsorption syndromes according to a detailed medical history.
  • Present alcoholism or drug abuse or use of medications that could interfere with the study such as corticosteroids, growth hormone, antiretroviral therapy. These conditions will be screened for by a detailed history and systems review.
  • Individuals with nut allergy are excluded.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Walnuts include many potentially beneficial micronutrients and phytochemicals, in this study we propose to examine the effects of walnuts independent of macronutrient content. The purpose of this proposal is to study in depth the short-term effects of walnut consumption in men and women with the metabolic syndrome.

Study Aim 1: To investigate the effects of walnuts (48gms per day over 3 days) on insulin resistance in subjects with the metabolic syndrome.

Read more

Study Aim 2: To investigate the effects of 48gms per day of walnuts over 3 days on lipids and inflammatory markers.

Study Aim 3: To assess the possible mechanisms of the biological effects of short-term walnut consumption through assessment of adipokines, resting metabolic rate, gene expression in white blood cells and the effect of walnuts when consumed as part of a mixed meal, on glucose excursions, insulin secretion and the excretion of gut peptides and free fatty acids.

Read the detailed description

During the whole study period, you will be asked to maintain a constant body weight and you will receive advice from the dietitian regarding a weight stable diet and exercise pattern. You will also be asked to avoid walnuts during the entire study period. The intervention and the measurements during each of the visits are described below.

If you agree to be in this study, you will be asked to read and sign this consent form. After you sign the consent form, the following things will happen:

  1. Screening Procedures: Screening procedures are tests and procedures that will be done to determine if you are eligible to take part in the research study. For this research study, the screening procedures include:
  2. A detailed medical history and interview about lifestyle factors and medication use
  3. A brief physical examination to document any abnormalities in your body appearance and measurement of weight, height and waist circumference.
  4. Drawing of blood from the forearm for fasting blood glucose (blood sugar), lipid profile (cholesterol and other fats in blood), creatinine (a measure of your kidney function), and complete blood count (CBC).
  5. Collection of urine for a HCG pregnancy test (women only) For the blood tests, you will be asked not to eat or drink anything (except water) from 8 pm the previous evening until you arrive for the study visit the following morning. Samples of your blood will be stored under code to be used for future research by the BIDMC investigators but your name will not be identified. If for any reason you have decided to withdraw from the study or if you have not met the criteria for enrollment into the study, all the blood drawn at the screening visit will be discarded. Next, you will meet with a research dietician to receive instructions for the 2-week run-in period (see below).
  6. Randomization Procedures: You will be randomly assigned (like the flip of a coin) to receive either walnut containing milkshake or placebo containing milkshake on your first visit. Each participant will receive walnut containing milkshake during one visit and a milkshake that looks and tastes the same but without walnuts (placebo) on the other visit but the order of the visits will be randomized.
  7. Research Procedures: If you qualify to take part in this research study, you will undergo these research procedures: Run-in period: You will meet with a research dietician who will provide instructions about maintaining your normal diet and physical activity pattern and about avoiding walnut-containing foods and drinks. Study Visit 1 and 2 Each study visit involves a 4-day (4 overnight) stay at the General Clinical Research Center. You will be admitted at 9pm the evening before the first day of the visit. You will be asked to complete a hunger questionnaire each morning before you have had anything to eat. You will receive a milkshake each morning containing either with or without walnuts. We will repeat the hunger questionnaire before your lunch each day. You will be provided with lunch and dinner based on what you like to eat. The calorie content of the lunch and dinner will be controlled so that you will neither gain or lose weight during your stay. Day 1 The following morning the following tests will be performed; Measure your weight, waist circumference, and blood pressure. Resting Metabolic Rate Fasting blood tests Body composition Mixed meal challenge You will receive your first milkshake as part of the mixed meal challenge. Day 2 On day 2 there is no testing but you will complete the hunger questionnaire and receive another milkshake for breakfast. Day 3 On day 3 you will have the following tests performed: Insulin Suppression Test Fasting blood sample At the end of the insulin suppression test, you will receive another milkshake. Day 4 On the morning of your last day you will have repeat testing as on the first day of the visit and will leave the hospital at mid-day after the testing is complete. Washout phase Between the 2 study visits you will enter a washout phase where you will continue your normal healthy diet and exercise but avoid walnuts in your diet. After 1 month of washout you will return to the GCRC for your second study visit.
  8. Tests performed during the study

Resting Metabolic Rate RMR is the amount of calories you burn without doing any physical work. Your RMR will be measured with a commonly used instrument. You will be asked to lie quietly in bed and stay awake with a large plastic hood over your head and upper body for about 20 minutes and breathe normally while the air you breathe out is being collected.

Fasting blood tests Blood samples will be used to measure sugar, insulin levels, lipids (LDL, HDL, and total cholesterol, triglycerides), hormones (such as leptin, resistin and adiponectin) and blood markers of inflammation (such as TNF and CRP). We will also perform a blood test to measure the expression of genes involved in metabolism in your white blood cells. For the blood tests, you will be asked not to eat or drink anything (except water) from 8 pm the previous evening until. In addition, you will be asked not to participate in vigorous physical activity on the day before the visit. Samples of your blood will be stored under code to be used for future related blood measurements by the BIDMC investigators but your name will not be identified.

Body composition To measure the amount of fat in your body we will use bioelectrical impedance analysis. During this procedure you will lie down and the speed of an electric signal through your body will be measured. This signal is not painful.

Mixed meal challenge You will have a small catheter (a small plastic tube) placed in a vein with a needle in your forearm to draw blood. This will prevent the need for multiple needle sticks for the required blood draws. The catheter will be taped to stay in place for approximately three hours. You will drink a milkshake and your blood will be drawn through the catheter 15 min after the milkshake is given and then at 30-minute intervals for 3 hours to measure how you metabolize the nutrient drink.

Insulin Suppression Test (also called Galvin's Index) This test consists of an overnight fast (nothing to eat or drink after 11pm the night before), after which two IV lines will be placed in your arms. Glucose, insulin,octreotide (a hormone commonly used in clinical practice for treating several different diseases) and albumin ( a protein found in blood) will be infused through the IV. Blood samples will be drawn through the other IV line at times -10 minutes, 0 minutes, and every 30 minutes for two and a half hours, then every 10 minutes for an additional 30 minutes.

Being tested
Walnuts, Control
Medical subject headings
Metabolic Syndrome, Diabetes Mellitus, Type 2, Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WalnutsDietary supplement

    48 Grams of Walnuts Daily

  • ControlDietary supplement

    Control Diet with No Walnuts

Study groups in NCT00525629
Study groupRoleWhat they receive
Walnut DietExperimental48 Grams of Walnuts Daily
Receives: Dietary Supplement: Walnuts
Control DietPlacebo comparatorIsocaloric Diet with No Walnuts
Receives: Dietary Supplement: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin Resistance

    HOMA-IR (homeostatic model assessment of insulin resistance) given in units as it is a ratio equation.

    Measured: 4 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2007 (estimated)
  2. Study startFeb 2007
  3. Primary completionDec 2008
  4. Study completionDec 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00525629
Sponsor's protocol ID
2006P000255
Status last verified
Jun 2017
First submitted
5 Sep 2007
Last updated
15 Dec 2017
Data monitoring committee
No

Publications

  • Brennan AM, Sweeney LL, Liu X, Mantzoros CS. Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity (Silver Spring). 2010 Jun;18(6):1176-82. doi: 10.1038/oby.2009.409. Epub 2009 Nov 12.

    PubMed 19910942

Questions about this trial

What is this clinical trial studying?

A study testing Walnuts in people with Metabolic Syndrome and Type 2 Diabetes, run by Christos Mantzoros at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Feb 2017). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin Resistance (time frame: 4 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00525629, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in